Elite Pharmaceuticals (ELTP) News Today $0.60 -0.01 (-1.48%) As of 10/16/2025 03:59 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock ELTP Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Elite Pharmaceuticals (OTCMKTS:ELTP) Stock Passes Above 50 Day Moving Average - Time to Sell?October 7, 2025 | marketbeat.comElite Pharmaceuticals (OTCMKTS:ELTP) Shares Gap Down - Should You Sell?September 30, 2025 | marketbeat.comElite Pharmaceuticals (OTCMKTS:ELTP) Trading Down 6.1% - Here's What HappenedSeptember 29, 2025 | marketbeat.comElite Pharmaceuticals (OTCMKTS:ELTP) Shares Down 5.3% - What's Next?September 20, 2025 | marketbeat.comElite Pharmaceuticals (OTCMKTS:ELTP) Stock Price Passes Above 50 Day Moving Average - Here's What HappenedSeptember 18, 2025 | marketbeat.comElite Pharmaceuticals (OTCMKTS:ELTP) Shares Gap Down - Time to Sell?September 16, 2025 | marketbeat.comElite Pharmaceuticals (OTCMKTS:ELTP) Shares Gap Up - Time to Buy?August 17, 2025 | marketbeat.comElite Pharmaceuticals (OTCMKTS:ELTP) Issues Earnings ResultsAugust 16, 2025 | marketbeat.comElite Pharmaceuticals (OTCMKTS:ELTP) Shares Down 6.9% - Time to Sell?August 15, 2025 | marketbeat.comElite Pharmaceuticals (OTCMKTS:ELTP) Stock Price Crosses Below Two Hundred Day Moving Average - Here's WhyAugust 7, 2025 | marketbeat.comElite Pharmaceuticals (OTCMKTS:ELTP) Shares Down 3.5% - Here's What HappenedJuly 21, 2025 | marketbeat.comElite Pharmaceuticals (OTCMKTS:ELTP) Stock Price Up 8.5% - Here's What HappenedJuly 18, 2025 | marketbeat.comElite Pharmaceuticals (OTCMKTS:ELTP) Shares Gap Down - What's Next?July 14, 2025 | marketbeat.comElite Pharmaceuticals (OTCMKTS:ELTP) Stock Price Down 5.5% - Time to Sell?July 8, 2025 | marketbeat.comElite Pharmaceuticals (OTCMKTS:ELTP) Stock Passes Above Fifty Day Moving Average - What's Next?July 8, 2025 | marketbeat.comElite Pharmaceuticals, Inc. (OTC:ELTP) Q4 2025 Earnings Call TranscriptJuly 3, 2025 | msn.comElite Pharmaceuticals (OTCMKTS:ELTP) Sees Strong Trading Volume - Should You Buy?July 2, 2025 | marketbeat.comElite Pharmaceuticals Inc (ELTP) Q4 2025 Earnings Call Highlights: Revenue Surge Amidst ...July 2, 2025 | finance.yahoo.comElite Pharmaceuticals, Inc. (ELTP) Q4 2025 Earnings Call TranscriptJuly 1, 2025 | seekingalpha.comElite Pharmaceuticals (OTCMKTS:ELTP) Stock Price Down 10.2% - Time to Sell?July 1, 2025 | marketbeat.comElite Pharmaceuticals (OTCMKTS:ELTP) Releases Quarterly Earnings ResultsJune 30, 2025 | marketbeat.comElite Pharmaceuticals (OTCMKTS:ELTP) Trading 6.9% Higher - Here's WhyJune 30, 2025 | marketbeat.comElite Pharmaceuticals, Inc. (ELTP) - Yahoo FinanceJune 26, 2025 | finance.yahoo.comElite Pharmaceuticals (OTCMKTS:ELTP) Shares Gap Up - Here's What HappenedJune 20, 2025 | marketbeat.comElite Pharmaceuticals (OTCMKTS:ELTP) Sees Large Volume Increase - Here's What HappenedJune 18, 2025 | marketbeat.comElite Pharmaceuticals (OTCMKTS:ELTP) Hits New 12-Month High - Here's WhyJune 17, 2025 | marketbeat.comElite Pharmaceuticals (OTCMKTS:ELTP) Shares Pass Below 200-Day Moving Average - What's Next?May 18, 2025 | marketbeat.comElite Pharmaceuticals (OTCMKTS:ELTP) Stock Price Crosses Below Two Hundred Day Moving Average - Here's What HappenedMay 10, 2025 | marketbeat.comElite Pharmaceuticals (OTCMKTS:ELTP) Shares Cross Below 200 Day Moving Average - Time to Sell?May 10, 2025 | marketbeat.comElite Pharmaceuticals (OTCMKTS:ELTP) Shares Cross Below 200 Day Moving Average - Here's What HappenedMay 2, 2025 | marketbeat.comElite Pharmaceuticals (OTCMKTS:ELTP) Stock Price Passes Below Two Hundred Day Moving Average - What's Next?April 24, 2025 | marketbeat.comElite Pharmaceuticals (OTCMKTS:ELTP) Share Price Crosses Below 200 Day Moving Average - Time to Sell?April 14, 2025 | marketbeat.comElite Pharmaceuticals (OTCMKTS:ELTP) Stock Price Crosses Below 200-Day Moving Average - Here's WhyApril 5, 2025 | marketbeat.comElite Pharmaceuticals (OTCMKTS:ELTP) Share Price Passes Below Two Hundred Day Moving Average - Time to Sell?March 27, 2025 | marketbeat.comElite Pharmaceuticals (OTCMKTS:ELTP) Stock Price Passes Below 200 Day Moving Average - Should You Sell?March 11, 2025 | marketbeat.comElite Pharmaceuticals (OTCMKTS:ELTP) Shares Cross Below 200-Day Moving Average - Here's What HappenedMarch 2, 2025 | marketbeat.comShort Interest in Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP) Increases By 7.6%January 1, 2025 | marketbeat.comElite Pharmaceuticals (OTCMKTS:ELTP) Share Price Crosses Below 50 Day Moving Average - Time to Sell?December 28, 2024 | marketbeat.comElite Pharmaceuticals, Inc.: Elite Pharmaceuticals Announces Commercial Launch of Generic Vyvanse(R)December 26, 2024 | finanznachrichten.deElite Pharmaceuticals (OTCMKTS:ELTP) Share Price Passes Above Fifty Day Moving Average - Here's WhyDecember 20, 2024 | marketbeat.comElite Pharmaceuticals Gains FDA Approval for Generic VyvanseNovember 19, 2024 | markets.businessinsider.comElite Pharmaceuticals, Inc. (PNK:ELTP) Q2 2025 Earnings Call TranscriptNovember 18, 2024 | msn.comElite Pharmaceuticals, Inc. (ELTP) Q2 2025 Earnings Conference Call TranscriptNovember 16, 2024 | seekingalpha.comElite Pharmaceuticals Reports Strong Q2 2025 Financial ResultsNovember 16, 2024 | markets.businessinsider.comElite Pharmaceuticals, Inc. (OTCMKTS:ELTP) Sees Large Decrease in Short InterestNovember 15, 2024 | marketbeat.comElite Pharmaceuticals Inc (ELTP) Q1 2025 Earnings Call Highlights: Record Revenue Growth and ...October 9, 2024 | finance.yahoo.comShort Interest in Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP) Grows By 10.5%September 18, 2024 | marketbeat.comElite Pharmaceuticals, Inc.: Elite Pharmaceuticals Announces Commercial Launch of Generic Methotrexate SodiumAugust 27, 2024 | finanznachrichten.deElite Pharmaceuticals (OTCMKTS:ELTP) Stock Price Passes Above 50 Day Moving Average of $0.19August 27, 2024 | marketbeat.comElite Pharmaceuticals, Inc. (OTCMKTS:ELTP) Sees Significant Decrease in Short InterestAugust 18, 2024 | marketbeat.com Get Elite Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ELTP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ELTP Media Mentions By Week ELTP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ELTP News Sentiment▼0.000.68▲Average Medical News Sentiment ELTP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ELTP Articles This Week▼00▲ELTP Articles Average Week Get the Latest News and Ratings for ELTP and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Elite Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Alvotech News Cidara Therapeutics News Catalyst Pharmaceuticals News Beam Therapeutics News Mineralys Therapeutics News Arcutis Biotherapeutics News Belite Bio News Agios Pharmaceuticals News Bausch Health Cos News ImmunityBio News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:ELTP) was last updated on 10/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elite Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elite Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
